Senior NGS Scientist and Technical Product Manager SOPHiA GENETICS
Traditional genomic analysis often requires sequential testing or a “one-size-fits-all” comprehensive genomic profiling (CGP) panel, leading to time-consuming workflows and increased costs. The new MSK-IMPACT® Flex powered with SOPHiA DDM™ solution offers a modular, end-to-end CGP approach based on the expertly designed content of MSK-IMPACT®, enabling agile analysis and high-resolution profiling of complex biomarkers (including TMB, MSI, and HRD) from DNA, RNA, and shallow whole genome sequencing.
In this session, you will: explore how this modular CGP approach improves lab efficiency and cost-effectiveness; hear experiences from an early adopter (speaker to be announced); learn how SOPHiA GENETICS’ proprietary RNA technology enhances detection of fusion, exon-skipping events and gene expression across solid tumors.
